Michael Anstey, Director at BICYCLE THERAPEUTICS plc (BCYC), bought 544,027 shares at $14.00 ($4.4M) on 2019-05-28, disclosed to the SEC on 2019-05-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 229,741 | $0 | 0.0% |
| 2 | $14.00 | 314,286 | $4.4M | 100.0% |
| Total | $8.09 avg | 544,027 | $4.4M | 100% |